A 54-year-old woman with IgG kappa multiple myeloma (diagnosed in November 2019) and a high-risk cytogenetic profile (t[4;14] and gain[1q]) had received frontline therapy with bortezomib ...

Pim-2 kinase is overexpressed in multiple myeloma (MM) cells to enhance their ... conjugated horse anti-mouse immunoglobulin G (IgG) antibody and horseradish peroxidase-conjugated goat anti ...

And we're also anticipating US and European approval for smoldering multiple myeloma. Each of these represents ... I have high confidence they are IGG-driven diseases and there's a lot of ...

Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

Study reveals multiple high-risk genetic changes predict worse multiple myeloma outcomes across all treatments.

In spite of recent advances in the management of multiple myeloma, cure has been elusive, with efforts to improve long-term ...

Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood cells that produce infection-fighting antibodies. Multiple myeloma is not hereditary, meaning it is not passed ...

After being diagnosed with multiple myeloma, Valarie Traynham turned her journey into a mission—raising awareness, educating ...

In a Community Case Forum in partnership with the North Carolina Oncology Association, Cristina Gasparetto, MD, discussed the ...

Regeneron on Friday said the recommendation covers adults with adults with relapsed and refractory multiple myeloma who have received at least three prior therapies, including a proteasome inhibitor, ...

Saad Usmani, Chief of MSK's Myeloma Service, says there are far more treatment options for multiple myeloma today compared with just 20 years ago. Note: This story was originally published in 2022 and ...